← Back
Data updated: Mar 10, 2026
CEPHALON
Oncology
CEPHALON is a major pharmaceutical company focused on Oncology.
1993
Since
6
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
2 drugs
Pipeline Strength Pro
Loading...